Characterization of Tau ELISAs for Evaluating Tau Accumulation in the Brains With Alzheimer’s Disease
Genetic Effects on Longitudinal Cognitive Decline During the Early Stages of Alzheimer's Disease
CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease
Additive interaction of mid- to late-life depression and cerebrovascular disease on the risk of dementia: A nationwide population-based cohort study
Plasma Neurofilament Light and Phosphorylated Tau 181 as Biomarkers of Alzheimer’s Disease Pathology and Clinical Disease Progression
An Integrative Multi-omics Approach Reveals New Central Nervous System Pathway Alterations in Alzheimer’s Disease
Performance of the QPLEXTM Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
Identification of Mild Cognitive Impairment Subtypes Predicting Conversion to Alzheimer’s Disease Using a Heterogeneous Mixture Learning
A Strategy for Identifying the Risk of Developing Alzheimer's Disease From Healthy Controls: Distance to Novelty Detection Boundary
Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy With Convolutional Neural Networks to Predict Cognitive Impairment